Trimurthi Drugs gets board nod for diversification of business
Advertisement
New Delhi: Pharma firm Trimurthi Drugs & Pharmaceuticals' board has approved diversification of its business activities.
The board has considered diversification of business activities of the company such as foods and food products, information technology and software consultancy, real estate, construction and warehousing, among others, Trimurthi Drugs & Pharmaceuticals said in a BSE filing.
The board has also considered change of the company's name to Trimurthi Ltd or such other name in order to make it in consonance with objects of the company, it added.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.